Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 6.96
(0.14%)
CNY 6.96
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 445.34 Million | 465.27 Million | 470.77 Million | 418.2 Million | 454.66 Million | 366.05 Million |
| Cost of Revenue | 109.72 Million | 119.25 Million | 118.37 Million | 115.2 Million | 113.74 Million | 97.79 Million |
| Gross Profit | 335.61 Million | 346.01 Million | 352.39 Million | 302.99 Million | 340.91 Million | 268.25 Million |
| Operating Expenses | 169.33 Million | 197.28 Million | 204.81 Million | 177.18 Million | 191.91 Million | 685.6 Million |
| Selling, General and Administrative Expenses | 107.09 Million | 111.8 Million | 119.27 Million | 108.26 Million | 120.54 Million | 613.19 Million |
| Research and Development Expenses | 65.76 Million | 68.89 Million | 67.31 Million | 56.41 Million | 56.44 Million | 50.91 Million |
| Other Expenses | -3.53 Million | 16.58 Million | 18.22 Million | 12.5 Million | 14.92 Million | -899.86 Thousand |
| Cost and Expenses | 279.05 Million | 316.53 Million | 323.19 Million | 292.38 Million | 305.66 Million | 783.4 Million |
| Operating Income | 166.28 Million | 170.29 Million | 162.58 Million | 136.85 Million | 159.73 Million | -412.4 Million |
| Interest Expense | 618.99 Thousand | 518.68 Thousand | 730.05 Thousand | 7655.50 | 6229.54 | 47.61 Thousand |
| Income Tax Expense | 18.74 Million | 24.74 Million | 19.43 Million | 18.41 Million | 19.04 Million | 10.93 Million |
| Earnings before Tax | 166.11 Million | 177.36 Million | 162.18 Million | 135.43 Million | 159.64 Million | -413.3 Million |
| Net Income | 147.37 Million | 152.62 Million | 142.75 Million | 117.02 Million | 140.59 Million | -424.24 Million |
| Earnings Per Share Basic | 0.37 | 0.38 | 0.36 | 0.29 | 0.35 | -2.11 |
| Earnings Per Share Diluted | 0.37 | 0.38 | 0.36 | 0.29 | 0.35 | -2.11 |
| Weighted Average Shares Outstanding | 398.3 Million | 401 Million | 401 Million | 401 Million | 401 Million | 200.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 398.3 Million | 401 Million | 401 Million | 401 Million | 401 Million | 200.84 Million |
| Gross Margin | 0.75 | 0.74 | 0.75 | 0.72 | 0.75 | 0.73 |
| EBIT Margin | 0.49 | 0.50 | 0.46 | 0.43 | 0.44 | -1.02 |
| Profit Margin | 0.33 | 0.33 | 0.30 | 0.28 | 0.31 | -1.16 |
| EBITDA | 219.33 Million | 232.23 Million | 220.02 Million | 183.57 Million | 206.68 Million | -373.9 Million |
| Earnings Before Tax Margin | 0.37 | 0.37 | 0.35 | 0.33 | 0.35 | -1.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 118.2 Million | 112.75 Million | 111.39 Million | 445.34 Million | 100.07 Million | 126.05 Million |
| Cost of Revenue | 29.83 Million | 29.84 Million | 24.77 Million | 109.72 Million | 24.54 Million | 30.46 Million |
| Gross Profit | 88.36 Million | 82.91 Million | 86.61 Million | 335.61 Million | 75.52 Million | 95.58 Million |
| Operating Expenses | 45.96 Million | 45.48 Million | 50.28 Million | 278.96 Million | 70.2 Million | 48.57 Million |
| Selling, General and Administrative Expenses | 84.03 Million | 33.71 Million | 31.23 Million | - | 11.51 Million | 43.92 Million |
| Research and Development Expenses | 19.17 Million | 10.51 Million | 18.61 Million | - | 18.53 Million | 15.46 Million |
| Other Expenses | -57.24 Million | -1.25 Million | -332.05 Thousand | -278.96 Million | -70.2 Million | -183.63 Thousand |
| Cost and Expenses | 75.8 Million | 75.33 Million | 75.06 Million | 278.96 Million | 70.2 Million | 79.03 Million |
| Operating Income | 43.19 Million | 37.42 Million | 42.61 Million | 166.37 Million | 29.86 Million | 50.87 Million |
| Interest Expense | 1.98 Million | 801.67 Thousand | 274.83 Thousand | 472 Thousand | 301.52 Thousand | 36.99 Thousand |
| Income Tax Expense | 7.71 Million | 4.15 Million | 3.89 Million | 18.74 Million | 2.64 Million | 7.08 Million |
| Earnings before Tax | 43.22 Million | 42.4 Million | 42.28 Million | 166.21 Million | 29.86 Million | 50.69 Million |
| Net Income | 35.5 Million | 38.24 Million | 38.39 Million | 147.37 Million | 27.13 Million | 43.6 Million |
| Earnings Per Share Basic | 0.09 | 0.10 | 0.10 | - | 0.07 | 0.11 |
| Earnings Per Share Diluted | 0.09 | 0.10 | 0.10 | - | 0.07 | 0.11 |
| Weighted Average Shares Outstanding | 394.59 Million | 394.59 Million | 383.92 Million | 398.3 Million | 390.84 Million | 401 Million |
| Weighted Average Shares Outstanding (Diluted) | 394.59 Million | 394.59 Million | 383.92 Million | 398.3 Million | 390.84 Million | 401 Million |
| Gross Margin | 0.75 | 0.74 | 0.78 | 0.75 | 0.75 | 0.76 |
| EBIT Margin | 0.38 | 0.45 | 0.38 | - | 0.31 | 0.41 |
| Profit Margin | 0.30 | 0.34 | 0.34 | 0.33 | 0.27 | 0.35 |
| EBITDA | 45.21 Million | 50.47 Million | 42.17 Million | - | 31.4 Million | 51.12 Million |
| Earnings Before Tax Margin | 0.37 | 0.33 | 0.38 | 0.37 | 0.30 | 0.40 |
603115
RYOOF
ASRV
603615
0J51
CLILF